Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/N1BI34 stock hub

BVMF/N1BI34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/N1BI34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

75B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/N1BI34

In the news

Latest news · BVMF/N1BI34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.9

P25 11.3P50 14.6P75 19.6

Trailing P/E21.5

P25 15.2P50 21.5P75 27.3

ROE22.5

P25 5.3P50 12.3P75 22.5

ROIC23.7

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/N1BI34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	2,000
Employees Change	400%
Employees Change Percent	28.57
Enterprise value	BRL 70.8B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	BRL 75B
Price	BRL 36.91
Price currency	BRL
Rev Per Employee	8,092,183.82x
Sector	Healthcare
Sic	2836
Symbol	bvmf/N1BI34
Website	https://www.neurocrine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.65%
EV Earnings	20.3x
EV/EBIT	18.1x
EV/EBITDA	16.27x
EV/FCF	16.33x
EV/Sales	4.66x
FCF yield	5.78%
Forward P/E	12.91x
P/B ratio	4.22x
P/E ratio	21.5x
P/S ratio	4.63x
PE Ratio10 Y	154.83x
PE Ratio3 Y	38.65x
PE Ratio5 Y	94.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.75%
EBITDA Margin	26.71%
FCF margin	26.8%
Gross margin	64.37%
Gross Profit	BRL 10.4B
Gross Profit Growth	29.51%
Gross Profit Growth Q	68.05%
Gross Profit Growth3 Y	23.11%
Gross Profit Growth5 Y	21.81%
Net Income	BRL 3.5B
Net Income Growth	118.64%
Net Income Growth Q	2,405.06%
Net Income Growth3 Y	118.61%
Net Income Growth5 Y	10.71%
Pretax Margin	30.22%
Profit Margin	21.55%
Profit Per Employee	BRL 1.7M
ROA	11.62
Roa5y	8.57
ROCE	19.6
ROE	22.5
Roe5y	12.08
ROIC	23.74
Roic5y	20.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.27%
Cagr3y	15.19%
Cagr5y	8.11%
EPS Growth	119.9
EPS Growth Q	2,310.5
EPS Growth3 Y	115.8
EPS Growth5 Y	9.71
FCF Growth	68.9%
FCF Growth Q	152.68%
FCF Growth3 Y	51.88%
FCF Growth5 Y	25.58%
OCF Growth	62.99%
OCF Growth Q	125%
OCF Growth3 Y	50.24%
OCF Growth5 Y	25.24%
Revenue Growth	28.59x
Revenue Growth Q	42.25x
Revenue Growth3 Y	24.74x
Revenue Growth5 Y	24.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.72
Assets	BRL 25.6B
Cash	BRL 6.9B
Current Assets	BRL 12B
Current Liabilities	BRL 4.1B
Debt	BRL 2.4B
Debt EBITDA	BRL 0.52
Debt Equity	BRL 0.14
Debt FCF	BRL 0.56
Equity	BRL 17.8B
Liabilities	BRL 7.8B
Long Term Assets	BRL 13.6B
Long Term Liabilities	BRL 3.7B
Net Cash	BRL 4.4B
Net Cash By Market Cap	BRL 5.93
Net Cash Growth	89.32%
Net Debt EBITDA	BRL -1.03
Net Debt Equity	BRL -0.25
Net Debt FCF	BRL -1.03
Tangible Book Value	BRL 17.8B
Tangible Book Value Per Share	BRL 177
WACC	5.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.93
Inventory Turnover	17.89
Net Working Capital	BRL 1.8B
Quick ratio	2.51
Working Capital	BRL 8.4B
Working Capital Turnover	BRL 11.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.27%
200-day SMA	35.8
3Y total return	52.84%
50-day SMA	35.49
50-day SMA vs 200-day SMA	50under200
5Y total return	47.64%
All Time High	44.95
All Time High Change	-17.89%
All Time High Date	2025-01-30
All Time Low	19.58
All Time Low Change	88.51%
All Time Low Date	2022-05-09
ATR	0.92
Beta	0.34
Ch YTD	-8.46
High	36.91
High52	44.18
High52 Date	2025-11-05
High52ch	-16.46%
Low	36.91
Low52	31.51
Low52 Date	2026-02-24
Low52ch	17.14%
Ma50ch	4%
Price vs 200-day SMA	3.11%
RSI	62.83
RSI Monthly	52.84
RSI Weekly	50.26
Sharpe ratio	0.24x
Sortino ratio	0.42
Total Return	0.68%
Tr YTD	-8.46
Tr1m	8.78%
Tr1w	11.78%
Tr3m	8.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 4.2B
Operating Income Growth	54.99
Operating Income Growth Q	684.8
Operating Income Growth3 Y	42.58
Operating Income Growth5 Y	21.63
Operating margin	25.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	99,291,905%
Shares Insiders	1.21%
Shares Institutions	100.25%
Shares Qo Q	-0.29%
Shares Yo Y	-0.68%
Short Ratio	4.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 3.2B
Average Volume	252.55x
Bv Per Share	176.7
CAPEX	BRL -169M
Ch1m	8.78
Ch1w	11.78
Ch1y	7.27
Ch3m	8.3
Ch3y	52.84
Ch5y	47.64
Ch6m	-8.18
Change	0%
Change From Open	0
Close	36.91
Days Gap	0
Depreciation Amortization	146,443,160
Dollar Volume	73.82
Earnings Date	2026-05-05
EBIT	BRL 4.2B
EBITDA	BRL 4.3B
EPS	BRL 33.92
F Score	6
FCF	BRL 4.3B
FCF EV Yield	6.13x
Financing CF	-33,908,713
Fiscal Year End	December
Founded	1,992
Graham Number	18.38677
Graham Upside	-50.18
Income Tax	BRL 1.4B
Investing CF	-4,094,085,780
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	BRL 18.39
Lynch Upside	-50.18
Ma150	36
Ma150ch	2.53%
Ma20	33.81
Ma20ch	9.18%
Net CF	377,690,890
Open	36.91
P FCF Ratio	17.29
P OCF Ratio	16.64
Ppne	2,643,839,600
Price Date	2026-05-08
Price EBITDA	BRL 17.35
Ptbv Ratio	4.22
Relative Volume	0.01x
Revenue	16,184,367,640x
SBC By Revenue	7.17x
Share Based Comp	1,159,677,968
Tax By Revenue	8.67x
Tax Rate	28.68%
Tr6m	-8.18%
Volume	2
Z Score	6.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/N1BI34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/N1BI34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/N1BI34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.2%

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/N1BI34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.8

Neutral momentum band

Price vs 200-day MA

+3.1%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/N1BI34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/N1BI34 stock rating?

bvmf/N1BI34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/N1BI34 analysis?

The full report lives at /stocks/bvmf/N1BI34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/N1BI34?

The latest report frames bvmf/N1BI34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/N1BI34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.